A Comprehensive Review of the 2018 United Network for Organ Sharing Heart Transplantation Policy Changes

Background: Historically, the heart allocation process relied heavily on local organ procurement organizations and geographic proximity, leading to disparities and inequitable outcomes driven by regional donor availability rather than clinical urgency. The 2018 revision of the heart transplantation allocation policy by the United Network for Organ Sharing (UNOS) significantly transformed the landscape of heart transplantation in the United States. This review critically examines the rationale, implementation, and impact of these policy changes, focusing on their effectiveness in addressing longstanding shortcomings, including geographical disparities, inadequate clinical risk stratification, and remaining challenges. Methods: A detailed review of published literature on the heart allocation system and national data from the Scientific Registry of Transplant Recipients was conducted. Results: The new heart allocation system significantly reduced waitlist mortality, from 139 deaths to 114 deaths per 100 patient-years, among the highest urgency patients. Meanwhile, median wait times for Status 1 candidates decreased from 112 to 39 days. The new policy particularly benefited patients assisted with temporary mechanical circulatory support devices such as extracorporeal membrane oxygenation (ECMO), intra-aortic balloon pumps, and Impella devices, whose transplantation rates increased substantially. Indeed, one-year survival rates for patients supported by ECMO improved after policy adoption (90% post-2018 vs. 74% pre-2018). However, the broadened geographic radius (500 nautical miles) intended to enhance equity promoted increased ischemic times (from 3.0 hours to 3.4 hours), raising concerns about long-term graft viability. Financial and logistical implications, such as increased organ transportation costs and resource utilization, were notable challenges. Additionally, stable patients with durable left ventricular assist devices (LVADs) experienced deprioritization unless complications arose, raising concerns about prolonged wait times and associated morbidity. Thus, despite clear improvements, persistent challenges remain. Conclusion: The changes to the heart allocation system brought significant benefits to the patients with high acuity status listings; however, some challenges remain. Meanwhile, the transition to a continuous distribution model, which employs a composite allocation score, holds promise for further refining patient prioritization by balancing medical urgency, geography, post-transplant survival predictions, and biological factors. Nonetheless, enhancements in donor organ preservation, standardized exception request processes, and optimized allocation algorithms remain essential to sustain the fairness, efficiency, and clinical effectiveness of the system.